Recurrent Ovarian Cancer Treatment
Links shared publicly online about this topic
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA
oncologynurseadvisor.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 7, 2010 at 8:20 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer http://goo.gl/fb/vAkMj
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - MPR
empr.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at empr.com
Most Recently Shared on June 7, 2010 at 8:14 pm By:
MPR News: Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer: Amgen announced that AMG 386, combin... http://bit.ly/cBbIUj
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9
Detecting breast cancer recurrence
physorg.com — “Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain and ovarian cancer before succumbing to the disease in their early ...” View full resource at physorg.com
Most Recently Shared on October 20, 2010 at 3:12 pm By:
Detecting breast cancer recurrence http://bit.ly/9do9jO
First Recurrent Gene Fusion Identified In Ovarian Cancer
medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2011 at 7:05 am By:
MNT Ovarian Cancer Health News
First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer
ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer
news-medical.net — “A study demonstrating the cost savings realized through the use of the ChemoFx® Drug Response Marker for assisting selection of treatment in recurrent ovarian cancer was published recently in the American Journal of Obstetrics and Gynecology (AJOG).” View full resource at news-medical.net
Most Recently Shared on June 4, 2010 at 9:26 am By:
ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer: A study demonstrating the cost... http://bit.ly/bn3YeK
Ovarian Cancer Treatment - Ovarian Cancer and Treatment
ovariancancer.about.com — “Self education and asking focused questions about ovarian cancer will alert your physician that you have spent time trying to learn something about your situation. This should spark better, more in-depth, discussions about your ovarian cancer treatment options.” View full resource at ovariancancer.about.com
Most Recently Shared on January 6, 2010 at 9:59 pm By:
Pacific Oncology Physician Group
Ovarian Cancer: Asking the Right Questions About Ovarian Cancer: http://short.to/12lj5 #cancer via @jcchancellor
Ovarian Cancer: Gynecologist Disputes Findings
medicalnewstoday.com — “An internationally-recognized gynecologic oncologist at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is warning that the results from a long-awaited global study of ovarian cancer” View full resource at medicalnewstoday.com
Most Recently Shared on October 18, 2010 at 1:05 pm By:
MNT Clinical Trials Health News
Ovarian Cancer: Gynecologist Disputes Findings http://mnt.to/3Lm8 #clinicaltrials
Personalized treatment for ovarian cancer
sciencedaily.com — “Researchers have shown that point mutations -- misspellings in a single letter of genetic code -- that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalized medicine.” View full resource at sciencedaily.com
Most Recently Shared on November 18, 2010 at 2:22 pm By:
Personalized treatment for ovarian cancer: Researchers have shown that point mutations -- misspellings in a sing... http://bit.ly/brua4r
Medical News: ASCO: Trabectedin Useful in Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Trabectedin may have a role in the treatment of recurrent ovarian cancer while sparing patients for a time from platinum-based regimens, according to several studies presented here.” View full resource at medpagetoday.com
Most Recently Shared on June 8, 2010 at 5:51 pm By:
ASCO: Trabectedin Useful in Recurrent Ovarian Cancer http://bit.ly/cdzGwZ
Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer
blog.mdlinx.com — “The findings of this study are opposite to what would be expected if these markers were good surrogates for treatment benefit.” View full resource at blog.mdlinx.com
Most Recently Shared on August 15, 2011 at 9:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer http://t.co/4Kziuul
New treatment shows promise against recurrent gynecologic cancers
physorg.com — “(BRONX, NY) - Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians ...” View full resource at physorg.com
Most Recently Shared on April 21, 2009 at 11:55 pm By:
New treatment shows promise against recurrent gynecologic cancers http://tinyurl.com/cgnpe9
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer
medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2011 at 9:07 am By:
MNT Ovarian Cancer Health News
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer
Ovarian Cancer: eMedicine Oncology
emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Medscape Oncology Health Site and Oncology
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer - QualityPoint Technologies
qualitypointtech.net — “CHICAGO (MedPage Today) -- Treatment with an investigational DNA repair inhibitor almost doubled progression-free survival in patients with relapsed, platinum-sensitive ovarian cancer, data from a randomized trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on May 18, 2011 at 11:45 pm By:
ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer: CHICAGO (MedPage Today) -- Treatment with an investigational ... http://bit.ly/kWiXXK
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
